Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eneida A Mendonca

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|September 11, 2024
Asthma innovations from the second International Collaborative Asthma Network (ICAN) forumNizar N Jarjour, Tonya Winders, Ann M Hansen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 15, 2019
Survivor and Clinician Assessment of Survivorship Care Plans for Hematopoietic Stem Cell Transplantation Patients: An Engineering, Primary Care, and Oncology Collaborative for Survivorship HealthColleen M Morken, Amye J Tevaarwerk, Amanda K Swiecichowski, et al.
Pediatrics|June 12, 2024
Better Guidelines and Policies: AAP's Partnership for Policy ImplementationChristoph U Lehmann, William G Adams, Juan D Chaparro, et al.
Computational and Structural Biotechnology Journal|April 13, 2016
MD-CTS: An integrated terminology reference of clinical and translational medicineWill Ray, Joe Finamore, Majid Rastegar-Mojarad, et al.
Cancer Immunology, Immunotherapy : CII|October 4, 2016
Killer immunoglobulin-like receptor (KIR) and KIR-ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2Wei Wang, Amy K Erbe, Mikayla Gallenberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2016
FCGR Polymorphisms Influence Response to IL2 in Metastatic Renal Cell CarcinomaAmy K Erbe, Wei Wang, Jacob Goldberg, et al.
Journal for Immunotherapy of Cancer|March 16, 2019
Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximabAmy K Erbe, Wei Wang, Lakeesha Carmichael, et al.
Pediatrics|October 29, 2014
Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitisShawn L Ralston, Allan S Lieberthal, H Cody Meissner, et al.
ERJ Open Research|June 1, 2023
Asthma innovations from the first International Collaborative Asthma Network forumBenjamin Gaston, Donna D Gardner, Kenzie Mahan, et al.
Frontiers in Immunology|June 30, 2017
HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer ImmunotherapyAmy K Erbe, Wei Wang, Patrick K Reville, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|September 11, 2024
Asthma innovations from the second International Collaborative Asthma Network (ICAN) forumNizar N Jarjour, Tonya Winders, Ann M Hansen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 15, 2019
Survivor and Clinician Assessment of Survivorship Care Plans for Hematopoietic Stem Cell Transplantation Patients: An Engineering, Primary Care, and Oncology Collaborative for Survivorship HealthColleen M Morken, Amye J Tevaarwerk, Amanda K Swiecichowski, et al.
Pediatrics|June 12, 2024
Better Guidelines and Policies: AAP's Partnership for Policy ImplementationChristoph U Lehmann, William G Adams, Juan D Chaparro, et al.
Computational and Structural Biotechnology Journal|April 13, 2016
MD-CTS: An integrated terminology reference of clinical and translational medicineWill Ray, Joe Finamore, Majid Rastegar-Mojarad, et al.
Cancer Immunology, Immunotherapy : CII|October 4, 2016
Killer immunoglobulin-like receptor (KIR) and KIR-ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2Wei Wang, Amy K Erbe, Mikayla Gallenberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2016
FCGR Polymorphisms Influence Response to IL2 in Metastatic Renal Cell CarcinomaAmy K Erbe, Wei Wang, Jacob Goldberg, et al.
Journal for Immunotherapy of Cancer|March 16, 2019
Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximabAmy K Erbe, Wei Wang, Lakeesha Carmichael, et al.
Pediatrics|October 29, 2014
Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitisShawn L Ralston, Allan S Lieberthal, H Cody Meissner, et al.
ERJ Open Research|June 1, 2023
Asthma innovations from the first International Collaborative Asthma Network forumBenjamin Gaston, Donna D Gardner, Kenzie Mahan, et al.
Frontiers in Immunology|June 30, 2017
HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer ImmunotherapyAmy K Erbe, Wei Wang, Patrick K Reville, et al.
Pageof 7